Astellas Pharma Inc (ALPMY)
9.53
+0.03
(+0.32%)
USD |
OTCM |
Apr 22, 16:00
Astellas Pharma PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| December 29, 2023 | 94.94 |
| December 28, 2023 | 96.30 |
| December 27, 2023 | 93.67 |
| December 26, 2023 | 93.15 |
| December 22, 2023 | 93.51 |
| December 21, 2023 | 92.71 |
| December 20, 2023 | 91.11 |
| December 19, 2023 | 92.07 |
| December 18, 2023 | 91.11 |
| December 15, 2023 | 90.64 |
| December 14, 2023 | 92.63 |
| December 13, 2023 | 93.67 |
| December 12, 2023 | 93.03 |
| December 11, 2023 | 94.78 |
| December 08, 2023 | 95.41 |
| December 07, 2023 | 97.82 |
| December 06, 2023 | 96.94 |
| December 05, 2023 | 96.70 |
| December 04, 2023 | 96.54 |
| December 01, 2023 | 97.98 |
| November 30, 2023 | 97.02 |
| November 29, 2023 | 96.54 |
| November 28, 2023 | 96.62 |
| November 27, 2023 | 97.82 |
| November 24, 2023 | 97.02 |
| Date | Value |
|---|---|
| November 22, 2023 | 96.78 |
| November 21, 2023 | 96.94 |
| November 20, 2023 | 97.98 |
| November 17, 2023 | 95.26 |
| November 16, 2023 | 92.31 |
| November 15, 2023 | 92.91 |
| November 14, 2023 | 93.59 |
| November 13, 2023 | 92.31 |
| November 10, 2023 | 93.99 |
| November 09, 2023 | 93.99 |
| November 08, 2023 | 93.83 |
| November 07, 2023 | 94.39 |
| November 06, 2023 | 94.31 |
| November 03, 2023 | 100.09 |
| November 02, 2023 | 98.69 |
| November 01, 2023 | 97.00 |
| October 31, 2023 | 101.25 |
| October 30, 2023 | 100.21 |
| October 27, 2023 | 100.69 |
| October 26, 2023 | 101.17 |
| October 25, 2023 | 102.76 |
| October 24, 2023 | 103.32 |
| October 23, 2023 | 103.56 |
| October 20, 2023 | 99.37 |
| October 19, 2023 | 99.49 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
11.67
Minimum
Oct 03 2019
110.50
Maximum
Sep 30 2023
27.86
Average
24.79
Median
Sep 13 2022
PE Ratio Benchmarks
| Takeda Pharmaceutical Co Ltd | 33.28 |
| Nxera Pharma Co Ltd | -- |
| PeptiDream Inc | 59.38 |
| Stemcell Holdings Inc | -- |
| Healios KK | -- |
PE Ratio Related Metrics
| PS Ratio | 1.567 |
| Price to Book Value | 1.603 |
| Price to Free Cash Flow | 18.09 |
| Price | 9.53 |
| Earnings Yield | -0.09% |
| Market Cap | 17.09B |
| Operating PE Ratio | 248.27 |